Gov. Paul LePage says clinical pharmaceutical drug trials not only save lives, but also boost Maine’s economy. At a news conference Friday in the State House, LePage said cancer killed more than 3,200 Mainers last year, and that 120,000 adult Mainers have diabetes. The governor says clinical trials are testing new medicines for both of those illnesses today in Maine. He says Maine researchers are engaged in cutting-edge biomedical science opportunities. LePage, who was joined business and drug industry leaders at Friday’s news conference, said his mother-in-law has had the opportunity to participate in clinical trials. He says that without them, “she would not be here.” The governor says developing new techniques in biotechnology not helps the economy, but also leads to safer and more effective treatments.